Skip to main content
OpenTrials
Completed

NCT Number: NCT04354285

24-hour Urinary Aldosterone And Endocrine System In Obesity

The study was aimed at investigating the relationship between hormone parameters and urinary aldosterone levels in 24h within a cohort of overweight and obesity.

Completed

Looking for future studies?

Notify Me

Key information

Study type

Observational

Primary location

National Institute of Gastroenterology IRCCS S. de Bellis

Castellana Grotte, Bari, 70132, Italy

About this study

Subjects were enrolled at the first examination whether they were not taking any medication, including oral contraceptives or drugs for osteoporosis, and free of significant medical illnesses, except obesity. Exclusion criteria were history of endocrinological diseases (diabetes mellitus, hypo or hyperthyroidism, hypopituitarism, etc.), chronic inflammatory diseases, stable known hypertension, angina pectoris, stroke, transient ischemic attack, heart infarction, congenital heart disease, malignancies, chronic inflammatory diseases, renal and liver failure, angina pectoris, myocardial infarction, heart failure, congenital heart diseases, minor and major stroke, and inherited thrombocytopenias and other major malignancies. Subjects were examined by means of the medical history, hormonal, metabolic and routine hematochemical parameters. The investigators provided for a clinical baseline evaluation that included extemporaneous ambulatory blood pressure (BP) and a physical assessment of body weight, Body Mass Index (BMI) and Waist Circumference (WC) as anthropometric parameters.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Overweight or obesity (BMI> 25 Kg/m2)

Exclusion criteria

  • Any kind of drug
  • Hypertension
  • Endocrine diseases (diabetes mellitus, hypo or hyperthyroidism, hypopituitarism, etc.),
  • Chronic inflammatory diseases
  • Renal failure
  • Liver failure
  • Angina pectoris
  • Myocardial infarction and heart failure
  • Genetic heart diseases
  • Thrombocytopenias

Treatment and study plan

Observational

Other

Observational

Primary outcomes

  1. Thyroid hormones (FT3, FT4)

    Time frame: Baseline

    FT3 (pg/mL), FT4 (pg/mL) concentration in serum

  2. TSH

    Time frame: Baseline

    TSH (mU/L) concentration in serum

  3. Urinary Aldosterone

    Time frame: Baseline

    24-h Urine Aldosterone (mg/24 h)

  4. Prolactin

    Time frame: Baseline

    Prolactin (ng/ml) concentration in serum

  5. Insulin

    Time frame: Baseline

    Insulin (mIU/L) concentration in serum

  6. Parathyroid Hormone

    Time frame: Baseline

    PTH (pg/mL) concentration in serum

Secondary outcomes

  1. Total cholesterol

    Time frame: Baseline

    Total cholesterol (mg/dL) concentrations in serum

  2. HDL cholesterol

    Time frame: Baseline

    HDL cholesterol (mg/dL) concentrations in serum

  3. LDL cholesterol

    Time frame: Baseline

    LDL cholesterol (mg/dL) concentrations in serum

  4. BMI

    Time frame: Baseline

    BMI (kg/m^2)

  5. Height

    Time frame: Baseline

    Height in meters

  6. Weight

    Time frame: Baseline

    Weight in kilograms

  7. Vitamin D

    Time frame: Baseline

    Vitamin D (ng/mL) concentration in serum

Sponsors and collaborators

Lead sponsor

Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis

Other

Registry information

Important dates

Study start
2019
Primary completion
2019
Study completion
2019
First posted
Apr 21, 2020
Registry last updated
Apr 21, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.